These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6174722)

  • 1. Stereospecificity of behavioural effects of viloxazine in bulbectomized rats does not correlate with its 5-HT-releasing action in vitro.
    Greenwood DT; Kemp JD; Middlemiss DN
    J Pharm Pharmacol; 1982 Jan; 34(1):38-41. PubMed ID: 6174722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo.
    Blackburn TP; Foster GA; Greenwood DT; Howe R
    Eur J Pharmacol; 1978 Dec; 52(3-4):367-74. PubMed ID: 729646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippman W; Pugsley TA
    Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavioral and radioreceptor analysis of viloxazine stereoisomers].
    Danchev ND; Rozhanets VV; Zhmurenko LA; Glozman OM; Zagorevskiĭ VA
    Biull Eksp Biol Med; 1984 May; 97(5):576-8. PubMed ID: 6326891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of viloxazine hydrochloride on the transport of noradrenaline, dopamine, 5-hydroxytryptamine and gamma-amino-butyric acid in rat brain tissue.
    Martin IL; Baker GB; Mitchell PR
    Neuropharmacology; 1978 Jun; 17(6):421-3. PubMed ID: 673157
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus.
    O'Connor WT; Leonard BE
    Neuropharmacology; 1986 Mar; 25(3):267-70. PubMed ID: 3703175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosterone, choline acetyltransferase and noradrenaline levels in olfactory bulbectomized rats in relation to changes in passive avoidance acquisition and open field activity.
    Broekkamp CL; O'Connor WT; Tonnaer JA; Rijk HW; Van Delft AM
    Physiol Behav; 1986; 37(3):429-34. PubMed ID: 3749302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
    van Riezen H; Schnieden H; Wren AF
    Br J Pharmacol; 1977 Aug; 60(4):521-8. PubMed ID: 907867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase by viloxazine in rats.
    Martinez C; Dominiak P; Kees F; Grobecker H
    Arzneimittelforschung; 1986 May; 36(5):800-3. PubMed ID: 2425816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral activating properties of indeloxazine HCl and its optical isomers.
    Shimizu-Sasamata M; Yamamoto M; Harada M
    Pharmacol Biochem Behav; 1993 Jun; 45(2):335-41. PubMed ID: 8327539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats.
    Joly D; Sanger DJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):199-204. PubMed ID: 2937066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The olfactory bulbectomized rat as a model of depression.
    Leonard BE
    Pol J Pharmacol Pharm; 1984; 36(5):561-9. PubMed ID: 6099892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of olfactory bulbectomy and DSP4 treatment in avoidance learning in the rat.
    Archer T; Söderberg U; Ross SB; Jonsson G
    Behav Neurosci; 1984 Jun; 98(3):496-505. PubMed ID: 6732927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of monoamine responses of denervated cells by a noradrenaline uptake inhibitor (viloxazine) [proceedings].
    Jones RS; Roberts MH
    Br J Pharmacol; 1978 Mar; 62(3):403P-404P. PubMed ID: 638334
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of chronically administered mianserin, 8-hydroxymianserin and desmethylmianserin on the 'open field' behaviour and brain noradrenaline metabolism in the olfactory bulbectomized rat.
    Leonard BE; O'Connor WT
    Neuropsychobiology; 1987; 18(3):118-21. PubMed ID: 3453427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of viloxazine on drug-induced inhibition of food intake in the rat.
    Pleece SA; Kirby MJ; Redfern PH
    J Pharm Pharmacol; 1980 Aug; 32(8):558-60. PubMed ID: 6106693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence for the central serotoninergic activity of viloxazine.
    Pawłowski L; Ruczyńska J; Wojtasik E
    Pol J Pharmacol Pharm; 1979; 31(4):261-9. PubMed ID: 523336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG profile of the anticonvulsant action of viloxazine in the rabbit.
    Tartara A; Bo P; Maurelli M; Savoldi F; Manzo L
    Farmaco Sci; 1983 Mar; 28(3):161-6. PubMed ID: 6852229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viloxazine as a betamimetic antidepressant drug.
    Bourin M; Ortega A; Larousse C
    Neuropsychobiology; 1987; 17(1-2):35-40. PubMed ID: 2819765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of viloxazine on cortical neurone responses to monoamines and acetylcholine [proceedings].
    Jones RS; Roberts MH
    Br J Pharmacol; 1977 Mar; 59(3):460P. PubMed ID: 843706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.